SARS-CoV-2 Multiplex kit
EurobioPlex SARS-CoV-2 is a CE marked test based on real-time reverse-transcription and amplification designed for qualitative determination of absence or presence of SARSCoV-2 in a RNA extract. This test is indicated to diagnose the occurrence of this infection in humans, or complement a proven or indeterminate diagnosis. The kit allows testing of 94 patients in addition to the positive and negative controls.
The EurobioPlex EBX-041 has been validated on the following specimen:
– Nasopharyngeal aspirate
– Bronchoalveolar fluid
– Nasal swab
The EBX-041 is a test using reverse-transcription and real-time amplification of viral RNA of SARS-CoV-2 based on amplification of 3 genes (RdRp Gene Target 1, RdRp Gene Target 2 and N Gene target 3). If at least one RdRp target is positive, a SARS-CoV-2 positive diagnostic can be called.
The kit contains one oligomix to detect the 3 targets, as well as an encapsidated control of RNA extraction and RT-PCR inhibition. The test is performed from extracted RNA from a sample, using one RT-PCR reaction in a single distinct well/tube.
The EurobioPlex FluCoSyn (EBX-042) is a real-time reverse transcription polymerase chain reaction (RT-PCR) amplification test in an RNA nucleic acid extract designed for the qualitative determination of the presence or absence of the following respiratory viruses:
– Influenza A virus (Flu A) and Influenza B virus (Flu B)
– Respiratory Syncytial Virus A and B (RSV A and B)
Please contact us if you need a specific product, we are meeting many customers’ unique requests.